DK0483614T3 - Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv - Google Patents

Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv

Info

Publication number
DK0483614T3
DK0483614T3 DK91117799.6T DK91117799T DK0483614T3 DK 0483614 T3 DK0483614 T3 DK 0483614T3 DK 91117799 T DK91117799 T DK 91117799T DK 0483614 T3 DK0483614 T3 DK 0483614T3
Authority
DK
Denmark
Prior art keywords
amino acids
metabolically
protect
heart tissue
ischemic heart
Prior art date
Application number
DK91117799.6T
Other languages
English (en)
Inventor
David Madsen
Gary Pace
Bruce Rowe
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24423981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0483614(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of DK0483614T3 publication Critical patent/DK0483614T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91117799.6T 1990-10-30 1991-10-18 Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv DK0483614T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60551490A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
DK0483614T3 true DK0483614T3 (da) 1995-10-30

Family

ID=24423981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91117799.6T DK0483614T3 (da) 1990-10-30 1991-10-18 Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv

Country Status (9)

Country Link
EP (1) EP0483614B1 (da)
JP (1) JPH04264024A (da)
AT (1) ATE123941T1 (da)
AU (1) AU655780B2 (da)
CA (1) CA2054134A1 (da)
DE (1) DE69110615T2 (da)
DK (1) DK0483614T3 (da)
ES (1) ES2074623T3 (da)
GR (1) GR3017321T3 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
DE69637676D1 (de) * 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
US7238727B2 (en) 2000-10-13 2007-07-03 Chugai Seiyaku Kabushiki Kaisha Compositions for improving lipid metabolism
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
WO2017025808A1 (en) * 2015-08-11 2017-02-16 Satoru Sugiyama System and method for improved blood circulation and maintaining mitochondrial energy production
JP6838752B2 (ja) * 2019-08-30 2021-03-03 株式会社東洋新薬 血流改善組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228127A1 (de) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Aminosaeuren-infusionsloesungen
WO1988001872A1 (en) * 1986-09-10 1988-03-24 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis

Also Published As

Publication number Publication date
ES2074623T3 (es) 1995-09-16
EP0483614A1 (en) 1992-05-06
DE69110615T2 (de) 1995-12-14
DE69110615D1 (de) 1995-07-27
CA2054134A1 (en) 1992-05-01
ATE123941T1 (de) 1995-07-15
JPH04264024A (ja) 1992-09-18
GR3017321T3 (en) 1995-12-31
AU655780B2 (en) 1995-01-12
AU8567091A (en) 1992-05-07
EP0483614B1 (en) 1995-06-21

Similar Documents

Publication Publication Date Title
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
SE8703625D0 (sv) New medical use
DK1039802T3 (da) Transdermal terapeutisk anordning med capsicin og capsaicinanaloger
DE68907124D1 (de) Verfahren zum stabilisieren von menschlichen albuminloesungen und so erhaltene loesung.
NO885797D0 (no) Karboksylsyrederivater med terapeutisk virkning og fremgangsmaate til deres fremstilling.
IE791235L (en) Acyl-derivatives of carnitine.
DK0483614T3 (da) Anvendelse af aminosyrer til beskyttelse af og metabolisk restitution af iskæmisk hjertevæv
DK0639979T3 (da) Ligand for c-kit-receptoren og fremgangsmåde til anvendelse heraf
NO155239C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, blandede salter av essensielle eller semi-essensielle aminosyrer og nitrogenfri analoger derav.
EP0238553A4 (en) TREATMENT OF A CATABOLIC DEREGULATION.
RU93004727A (ru) Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии
NO146599C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav
NO995944D0 (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
NO177859C (no) Fremgangsmåte til produksjon av angiogen faktor
LV10384A (lv) Sastavs asins plazmas stabilizacijai pasterizacijas laika
SE7702251L (sv) Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
ATE68474T1 (de) Aktive substanz in der kardiovaskulaeren therapie.
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
ZA75903B (en) N-(1'-allylpyrrolidinyl2'-methyl)2-methoxy 4,5-azimido benzamide, its pharmaceutically acceptable addition salts with acids and methods for its preparation
SE8401907D0 (sv) New phenoxypropanol amine salts and pharmaceutical preparations thereof
RU98111356A (ru) Способ лечения ожогового шока
NL7411979A (en) (1-Alpha-aminoisobutyric acid)-c9is - with higher potencies than natural ACTH
JPS51121524A (en) Agents for liver dysfunction
GB2000767A (en) Therapeutic propylamine derivatives